News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

The EPO has recently issued updated Guidelines for Examination, which entered into force on 1 March 2024. Some of the most significant modifications have been made to the guidance surroundin...

Tools like ChatGPT and Bard promise to simplify the patent process, slashing costs and saving time. However, when it comes to safeguarding your intellectual property, these AI assistants can...

A new study from the European Patent Office and the EU Intellectual Property Office has shed light on the undeniable advantages of IP rights for startups.

The smart health wearables market in Europe is booming, and intellectual property protection is essential for success. Discover the keys to safeguarding your IP in our latest article, where ...

Marks & Clerk AI Report 2023 reveals an interesting insight into the latest trends in patent applications

Addressing the antimicrobial resistance crisis will require a multifaceted approach - could extending patent terms encourage pharmaceutical companies to drive innovation in this area? Potte...

Inside Green Innovation: Progress Report 2022, from leading intellectual property firm Appleyard Lees’, analyses patent filings across several key environmental issues facing the world, in...

N-Site Video Launch

Jun 17th 2021

We’re pleased to announce the launch of our N-Site Video which covers who we are, what we do and how we can offer guidance to Life Sciences companies.

The medtech sector has remained at the forefront of innovation during the pandemic with a multitude of new technologies being developed to help tackle the coronavirus crisis

Why aren’t the major pharmaceutical companies filing patents to AI-related inventions?

Recent cell and gene therapy product approvals have allowed the pharmaceutical industry to start a new age of innovation regarding cancer treatment, moving away from the more homogeneous the...

At a time when many businesses are thinking of onshoring some or all of their operations to minimise risk, it is good to know that Europe remains an attractive place for innovators.

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners